Regulon

Regulon: R-3292

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
82.9368114Pr-39Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
3371 ENSG00000041982 TNC F5H7V9
3842 ENSG00000083312 TNPO1 Q92973
285 ENSG00000091879 ANGPT2 O15123
3488 ENSG00000115461 IGFBP5 P24593
23022 ENSG00000129116 PALLD B2RTX2
133 ENSG00000148926 ADM P35318
25948 ENSG00000170852 KBTBD2 Q8IY47
10801 ENSG00000282302 9-Sep Q9UHD8

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
AMG-780ANGPT2AntibodyINHIBITORAngiopoietin-2 inhibitor10
MEDI-3617ANGPT2AntibodyINHIBITORAngiopoietin-2 inhibitor10
ENIBARCIMABADMAntibodySTABILISERADM stabiliser20
F16SIP 131ITNCAntibodyBINDING AGENTTenascin binding agent20
TREBANANIBANGPT2ProteinINHIBITORAngiopoietin-2 inhibitor32
F16IL2TNCAntibodyOTHERTenascin other20
VANUCIZUMABVEGFAAntibodyINHIBITORAngiopoietin-2 inhibitor20
FARICIMABANGPT2AntibodyINHIBITORVascular endothelial growth factor A inhibitor30
CVX-060ANGPT2UnknownINHIBITORAngiopoietin-2 inhibitor22
NESVACUMABANGPT2AntibodyINHIBITORAngiopoietin-2 inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-3292

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-10451ADAMTS10up-regulatesNKX2-2activatesR-3292171Drugs (10)
CMF-18096DLGAP2up-regulatesNKX2-2activatesR-3292172Drugs (10)
CMF-21193ATMup-regulatesNKX2-2activatesR-3292172Drugs (10)
CMF-24170HEATR5Aup-regulatesNKX2-2activatesR-3292171Drugs (10)